Ehud (Udi) Goldin
About Ehud (Udi) Goldin
Ehud (Udi) Goldin is a Staff Scientist at the National Institutes of Health and Vice President of Biology at BioSuperior Technology, Inc. He has extensive expertise in molecular biology, particularly in the diagnosis and treatment of genetic diseases affecting brain development.
Current Role at National Institutes of Health
Ehud Goldin has been serving as a Staff Scientist at the National Institutes of Health (NIH) in Bethesda, MD, since 2005. With a tenure of 19 years, he focuses on various aspects of neurobiology and biomarker discovery for genetic diseases affecting brain development. His role involves conducting research that contributes to understanding neurological conditions and developing potential therapeutic strategies.
Experience at SENS Research Foundation
From 2013 to 2015, Ehud Goldin held the position of Chief Scientist at the SENS Research Foundation. During his two-year tenure, he contributed to research initiatives aimed at understanding and addressing age-related diseases. His work involved applying his expertise in molecular biology and biomarker discovery to innovative projects within the organization.
Academic Background and Education
Ehud Goldin's academic journey includes a Doctor of Philosophy (PhD) in Neurobiology and Neurosciences from the Weizmann Institute of Science, completed between 1984 and 1989. He also pursued post-doctoral studies at the National Institutes of Health from 1989 to 1992. Earlier, he earned a Master of Science (MS) in Animal Sciences from The Hebrew University (1981-1983) and a Bachelor of Science (BS) in Biology from Tel Aviv University (1977-1980).
Expertise in Genetic Diseases and Drug Development
Ehud Goldin specializes in the diagnosis and biomarker discovery for genetic diseases, particularly those affecting brain development. His expertise extends to drug screening and development for lysosomal storage disorders, including Gaucher disease, Mucolipidosis Type IV, and Fabry disease. He has significant experience in empirical and theoretical disease modeling, especially concerning vascular diseases and stroke.
Professional Experience at BioSuperior Technology, Inc.
Since 2018, Ehud Goldin has been serving as Vice President of Biology at BioSuperior Technology, Inc. in Sunnyvale, CA. In this role, he utilizes his extensive background in molecular biology and drug development to lead biological research initiatives. His responsibilities include overseeing projects related to genetic diseases and contributing to the advancement of therapeutic solutions.